Industry: Chemical & Material
Published Date: 2025-02-15
Pages: 77 Pages
Report ld: 3947133
Request Sample
Customized Report
The global Isotope-Labeled Excipient market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario, a high number of intermediaries, and lack of awareness among end users.
The North America Isotope-Labeled Excipient market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Isotope-Labeled Excipient include Molecular Isotope Technologies, Cambridge Isotope Laboratories, CIL Isotope Separations, Membrane Receptor Technologies, Marshall Isotopes, CortecNet, Medical Isotopes, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Isotope-Labeled Excipient market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Isotope-Labeled Excipient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Isotope-Labeled Excipient in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Isotope-Labeled Excipient manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Isotope-Labeled Excipient revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Isotope-Labeled Excipient Product Scope
1.2 Isotope-Labeled Excipient by Type
1.2.1 Global Isotope-Labeled Excipient Sales by Type (2020 & 2024 & 2031)
1.2.2 Deuterium
1.2.3 Carbon-13
1.2.4 Oxygen-18
1.2.5 Nitrogen-15
1.2.6 Other Stable Isotopes
1.3 Isotope-Labeled Excipient by Application
1.3.1 Global Isotope-Labeled Excipient Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Agriculture
1.3.3 Biomolecular NMR
1.3.4 Metabolic And Nutrition
1.3.5 Research
1.4 Global Isotope-Labeled Excipient Market Estimates and Forecasts (2020-2031)
1.4.1 Global Isotope-Labeled Excipient Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Isotope-Labeled Excipient Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Isotope-Labeled Excipient Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Isotope-Labeled Excipient Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Isotope-Labeled Excipient Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Isotope-Labeled Excipient Sales Market Share by Region (2020-2025)
2.2.2 Global Isotope-Labeled Excipient Revenue Market Share by Region (2020-2025)
2.3 Global Isotope-Labeled Excipient Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Isotope-Labeled Excipient Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Isotope-Labeled Excipient Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Isotope-Labeled Excipient Market Size and Prospective (2020-2031)
2.4.2 Europe Isotope-Labeled Excipient Market Size and Prospective (2020-2031)
2.4.3 China Isotope-Labeled Excipient Market Size and Prospective (2020-2031)
2.4.4 Japan Isotope-Labeled Excipient Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Isotope-Labeled Excipient Historic Market Review by Type (2020-2025)
3.1.1 Global Isotope-Labeled Excipient Sales by Type (2020-2025)
3.1.2 Global Isotope-Labeled Excipient Revenue by Type (2020-2025)
3.1.3 Global Isotope-Labeled Excipient Price by Type (2020-2025)
3.2 Global Isotope-Labeled Excipient Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Isotope-Labeled Excipient Sales Forecast by Type (2026-2031)
3.2.2 Global Isotope-Labeled Excipient Revenue Forecast by Type (2026-2031)
3.2.3 Global Isotope-Labeled Excipient Price Forecast by Type (2026-2031)
3.3 Different Types Isotope-Labeled Excipient Representative Players
4 Global Market Size by Application
4.1 Global Isotope-Labeled Excipient Historic Market Review by Application (2020-2025)
4.1.1 Global Isotope-Labeled Excipient Sales by Application (2020-2025)
4.1.2 Global Isotope-Labeled Excipient Revenue by Application (2020-2025)
4.1.3 Global Isotope-Labeled Excipient Price by Application (2020-2025)
4.2 Global Isotope-Labeled Excipient Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Isotope-Labeled Excipient Sales Forecast by Application (2026-2031)
4.2.2 Global Isotope-Labeled Excipient Revenue Forecast by Application (2026-2031)
4.2.3 Global Isotope-Labeled Excipient Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Isotope-Labeled Excipient Application
5 Competition Landscape by Players
5.1 Global Isotope-Labeled Excipient Sales by Players (2020-2025)
5.2 Global Top Isotope-Labeled Excipient Players by Revenue (2020-2025)
5.3 Global Isotope-Labeled Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isotope-Labeled Excipient as of 2024)
5.4 Global Isotope-Labeled Excipient Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Isotope-Labeled Excipient, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Isotope-Labeled Excipient, Product Type & Application
5.7 Global Key Manufacturers of Isotope-Labeled Excipient, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Isotope-Labeled Excipient Sales by Company
6.1.1.1 North America Isotope-Labeled Excipient Sales by Company (2020-2025)
6.1.1.2 North America Isotope-Labeled Excipient Revenue by Company (2020-2025)
6.1.2 North America Isotope-Labeled Excipient Sales Breakdown by Type (2020-2025)
6.1.3 North America Isotope-Labeled Excipient Sales Breakdown by Application (2020-2025)
6.1.4 North America Isotope-Labeled Excipient Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Isotope-Labeled Excipient Sales by Company
6.2.1.1 Europe Isotope-Labeled Excipient Sales by Company (2020-2025)
6.2.1.2 Europe Isotope-Labeled Excipient Revenue by Company (2020-2025)
6.2.2 Europe Isotope-Labeled Excipient Sales Breakdown by Type (2020-2025)
6.2.3 Europe Isotope-Labeled Excipient Sales Breakdown by Application (2020-2025)
6.2.4 Europe Isotope-Labeled Excipient Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Isotope-Labeled Excipient Sales by Company
6.3.1.1 China Isotope-Labeled Excipient Sales by Company (2020-2025)
6.3.1.2 China Isotope-Labeled Excipient Revenue by Company (2020-2025)
6.3.2 China Isotope-Labeled Excipient Sales Breakdown by Type (2020-2025)
6.3.3 China Isotope-Labeled Excipient Sales Breakdown by Application (2020-2025)
6.3.4 China Isotope-Labeled Excipient Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Isotope-Labeled Excipient Sales by Company
6.4.1.1 Japan Isotope-Labeled Excipient Sales by Company (2020-2025)
6.4.1.2 Japan Isotope-Labeled Excipient Revenue by Company (2020-2025)
6.4.2 Japan Isotope-Labeled Excipient Sales Breakdown by Type (2020-2025)
6.4.3 Japan Isotope-Labeled Excipient Sales Breakdown by Application (2020-2025)
6.4.4 Japan Isotope-Labeled Excipient Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Molecular Isotope Technologies
7.1.1 Molecular Isotope Technologies Company Information
7.1.2 Molecular Isotope Technologies Business Overview
7.1.3 Molecular Isotope Technologies Isotope-Labeled Excipient Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Molecular Isotope Technologies Isotope-Labeled Excipient Products Offered
7.1.5 Molecular Isotope Technologies Recent Development
7.2 Cambridge Isotope Laboratories
7.2.1 Cambridge Isotope Laboratories Company Information
7.2.2 Cambridge Isotope Laboratories Business Overview
7.2.3 Cambridge Isotope Laboratories Isotope-Labeled Excipient Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Cambridge Isotope Laboratories Isotope-Labeled Excipient Products Offered
7.2.5 Cambridge Isotope Laboratories Recent Development
7.3 CIL Isotope Separations
7.3.1 CIL Isotope Separations Company Information
7.3.2 CIL Isotope Separations Business Overview
7.3.3 CIL Isotope Separations Isotope-Labeled Excipient Sales, Revenue and Gross Margin (2020-2025)
7.3.4 CIL Isotope Separations Isotope-Labeled Excipient Products Offered
7.3.5 CIL Isotope Separations Recent Development
7.4 Membrane Receptor Technologies
7.4.1 Membrane Receptor Technologies Company Information
7.4.2 Membrane Receptor Technologies Business Overview
7.4.3 Membrane Receptor Technologies Isotope-Labeled Excipient Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Membrane Receptor Technologies Isotope-Labeled Excipient Products Offered
7.4.5 Membrane Receptor Technologies Recent Development
7.5 Marshall Isotopes
7.5.1 Marshall Isotopes Company Information
7.5.2 Marshall Isotopes Business Overview
7.5.3 Marshall Isotopes Isotope-Labeled Excipient Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Marshall Isotopes Isotope-Labeled Excipient Products Offered
7.5.5 Marshall Isotopes Recent Development
7.6 CortecNet
7.6.1 CortecNet Company Information
7.6.2 CortecNet Business Overview
7.6.3 CortecNet Isotope-Labeled Excipient Sales, Revenue and Gross Margin (2020-2025)
7.6.4 CortecNet Isotope-Labeled Excipient Products Offered
7.6.5 CortecNet Recent Development
7.7 Medical Isotopes
7.7.1 Medical Isotopes Company Information
7.7.2 Medical Isotopes Business Overview
7.7.3 Medical Isotopes Isotope-Labeled Excipient Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Medical Isotopes Isotope-Labeled Excipient Products Offered
7.7.5 Medical Isotopes Recent Development
8 Isotope-Labeled Excipient Manufacturing Cost Analysis
8.1 Isotope-Labeled Excipient Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Isotope-Labeled Excipient
8.4 Isotope-Labeled Excipient Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Isotope-Labeled Excipient Distributors List
9.3 Isotope-Labeled Excipient Customers
10 Isotope-Labeled Excipient Market Dynamics
10.1 Isotope-Labeled Excipient Industry Trends
10.2 Isotope-Labeled Excipient Market Drivers
10.3 Isotope-Labeled Excipient Market Challenges
10.4 Isotope-Labeled Excipient Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Isotope-Labeled Excipient was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 129
USD 3950.00
(Single User License)
The global Isotope-Labeled Excipient market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 129
USD 2900.00
(Single User License)
The global Isotope-Labeled Excipient market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 140
USD 4900.00
(Single User License)
The global market for Isotope-Labeled Excipient was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 99
USD 3950.00
(Single User License)
The global market for Isotope-Labeled Excipient was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 91
USD 2900.00
(Single User License)
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario, a high number of intermediaries, and lack of awareness among end users.
Published Date: 2024-04-25
Pages: 96
USD 4900.00
(Single User License)
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario, a high number of intermediaries, and lack of awareness among end users.
Published Date: 2024-02-06
Pages: 94
USD 2900.00
(Single User License)
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario, a high number of intermediaries, and lack of awareness among end users.
Published Date: 2024-01-11
Pages: 107
USD 3950.00
(Single User License)
The global market for Isotope-Labeled Excipient was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 129
The global Isotope-Labeled Excipient market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 129
The global Isotope-Labeled Excipient market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 140
The global market for Isotope-Labeled Excipient was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 99
The global market for Isotope-Labeled Excipient was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 91
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario, a high number of intermediaries, and lack of awareness among end users.
Published: 2024-04-25
Pages: 96
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario, a high number of intermediaries, and lack of awareness among end users.
Published: 2024-02-06
Pages: 94
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario, a high number of intermediaries, and lack of awareness among end users.
Published: 2024-01-11
Pages: 107
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now